Back to News
Market Impact: 0.1
Peptide Tracker Adds Symptom Tracking and Weekly Check-Ins in v2.25.0
Source: PR Newswire
Product LaunchesHealthcare & BiotechTechnology & Innovation
Peptide Tracker released app version 2.25.0, adding a feature that lets users log symptoms, rate their impact, and review which doses they took on days symptoms appeared. The brief announcement provides no user, revenue, or market-impact figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- AI stock sell-off ramps up over debt-fueled data center spending fears: ‘Full-blown crisis of confidence'
- All the news about the iPhone Duo
- The Tesla Roadster should go into production in 2028, but don't get your hopes up
- Ukraine advances in occupied Donetsk as Trump hands Putin diesel deal
- Apple’s $1,999 iPhone Duo puts the company's status-symbol power to the test
- Yields continue to rattle investors. These sectors are most at risk if rates stay elevated